Johanna Wennerblom

Johanna Wennerblom

Auto-generated profile, based on publicly available information

Johanna Wennerblom

Department of Surgery, Institute of Clinical Sciences Sahlgrenska Academy at the University of Gothenburg and Region of Västra Götaland Sahlgrenska University Hospital Gothenburg Sweden

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
JWJ Wennerblom
J Wennerblom
ZAZ Ateeb
Z Ateeb
CJC Jönsson
C Jönsson
BBB Björnsson
B Björnsson
BTB Tingstedt
B Tingstedt
MCM Del Chiaro
M Del Chiaro
Postoperative pancreatic fistula is the leading cause of morbidity after distal pancreatectomy. Strategies investigated to reduce the incidence have been disappointing. Recent data showed a reduction in postoperative pancreatic fistula with the use of synthetic mesh reinforcement of the staple line. An RCT was conducted between May 2014 and February 2016 at four tertiary referral centres in Sweden. Patients scheduled for distal pancreatectomy were eligible. Enrolled patients were randomized during surgery to stapler transection with biological reinforcement or standard stapler transection. Patients were blinded to the allocation. The primary endpoint was the development of any postoperative pancreatic fistula. Secondary endpoints included morbidity, mortality, and duration of hospital stay. Some 107 patients were randomized and 106 included in an intention-to-treat analysis (56 in reinforced stapling group, 50 in standard stapling group). No difference was demonstrated in terms of clinically relevant fistulas (grade B and C): 6 of 56 (11 per cent) with reinforced stapling versus 8 of 50 (16 per cent) with standard stapling (P = 0.332). There was no difference between groups in overall postoperative complications: 45 (80 per cent) and 39 (78 per cent) in reinforced and standard stapling groups respectively (P = 0.765). Duration of hospital stay was comparable: median 8 (range 2–35) and 9 (2–114) days respectively (P = 0.541). Biodegradable stapler reinforcement at the transection line of the pancreas did not reduce postoperative pancreatic fistula compared with regular stapler transection in distal pancreatectomy. Registration number: NCT02149446 (http://www.clinicaltrials.gov).

1 January 2007 in Gastroenterology
Verified
Journal Article
Closed access
ACAnna Casselbrant
Anna Casselbrant
AEAnders Edebo
Anders Edebo
JWJohanna Wennerblom
Johanna Wennerblom
HLHans Lönroth
Hans Lönroth
HHHerbert F. Helander
Herbert F. Helander
LFLars Fändriks
Lars Fändriks


21 December 2017 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
JWJohanna Wennerblom
Johanna Wennerblom
PSPushpa Saksena
Pushpa Saksena
CJClaes Jönsson
Claes Jönsson
ATAnders Thune
Anders Thune
Objectives: An investigation of patients with pancreatic carcinoma aims to identify those who will benefit from surgery. Physical examination, radiology and laboratory findings are helpful. Most prognostic markers, such as lymph node status, micro metastasis and tumour differentiation, are not preoperatively accessible. Metastatic disease in lymph node 8a (Ln8a) in patients operated for pancreatic carcinoma has been reported to be a predictor of shorter overall survival (OS). This lymph node can be assessed preoperatively through resection (possibly even with laparoscopy) and subsequent histopathology. The value of the procedure is disputed. The aim of this study is to investigate whether metastatic disease in Ln8a is a predictor of decreased OS. Materials and methods: In patients with suspected pancreatic or periampullary carcinoma, who were operated with pancreatoduodenectomy (PD), Ln8a was separately resected and analysed with standard and immuno-histochemical methods. Patients with or without metastasis in Ln8a were compared regarding OS. Results: Between 2008 and 2011, 122 consecutive patients were eligible and 87 were resected and had LN8a analysed separately. Sixteen patients were Ln8a + and 71 were Ln8a-. Patients with Ln8a + had a significantly reduced median OS as compared to patients with Ln8a– (0.74 (95% CI 0.26–1.26) versus 5.91 years (95% CI 2.91–), p < .001). Conclusion: Ln8a + was associated with a marked reduction of OS, indicating a possible role in the future preoperative workup in patients with a suspicion of pancreatic cancer.

11 March 2026 in International Journal of Surgery
Verified
Journal Article
Open access
ARArtur Rebelo
Artur Rebelo
BABodil Andersson
Bodil Andersson
SBSamik Kumar Bandyopadhyay
Samik Kumar Bandyopadhyay
PBPaulina Bereza-Carlson
Paulina Bereza-Carlson
FBFrederik Berrevoet
Frederik Berrevoet
Jörg KleeffJörg Kleeff
Jörg Kleeff
Objective: To evaluate short-term outcomes and identify predictors of morbidity and mortality following multivisceral oncologic resections involving the pancreas. Summary background data: Multivisceral resections including the pancreas are required for locally advanced abdominal malignancies but are associated with considerable perioperative risk. While smaller series suggest acceptable outcomes in selected patients, large-scale international data are lacking to guide surgical decision-making and risk stratification. Methods: This was a retrospective cohort study of 1283 patients from 31 international centers who underwent multivisceral oncologic resections involving the pancreas. Patient demographics, tumor characteristics, operative details, and 90-day postoperative outcomes were analyzed. Results: The cohort had a mean age of 64.7 years, and 54.7% were male. Distal pancreatectomy was the most frequent procedure (60.5%), and R0 resection was achieved in 60.9% of cases. The 90-day mortality was 6.9%, highest in patients with gastric adenocarcinoma (16.7%). Major complications (Clavien–Dindo grade III–V) occurred in 34.4% of patients. Higher ASA classification and open surgical approach were independently associated with increased morbidity and mortality. Prolonged operative time was associated with morbidity only. Female gender and treatment at high-volume centers were protective. In patients with pancreatic tumors, resection involving the colon (OR: 1.78, P < 0.001), stomach (OR: 1.33, P = 0.042), or three or more organs (OR: 1.75, P = 0.006) significantly increased complication rates. Conclusions: Multivisceral resections involving the pancreas are associated with relevant perioperative risk. Optimizing patient selection, favoring minimally invasive techniques when feasible in selected patients, and centralizing care to high-volume centers may help improve outcomes for these complex surgical procedures.

4 March 2025 in British Journal of Surgery
Verified
Journal Article
Open access
ABAkseli Bonsdorff
Akseli Bonsdorff
TKTrond Kjeseth
Trond Kjeseth
JKJakob Kirkegård
Jakob Kirkegård
CPCharles de Ponthaud
Charles de Ponthaud
PGPoya Ghorbani
Poya Ghorbani
VSVille Sallinen
Ville Sallinen
Background: Every fifth patient undergoing left pancreatectomy develops a postoperative pancreatic fistula (POPF). Accurate POPF risk prediction could help. Two independent preoperative prediction models have been developed and externally validated: DISPAIR and D-FRS. The aim of this study was to validate, compare, and possibly update the models. Methods: Patients from nine high-volume pancreatic surgery centres (8 in Europe and 1 in North America) were included in this retrospective cohort study. Inclusion criteria were age over 18 years and open or minimally invasive left pancreatectomy since 2010. Model performance was assessed with discrimination (receiver operating characteristic (ROC) curves) and calibration (calibration plots). The updated model was developed with logistic regression and internally-externally validated. Results: Of 2284 patients included, 497 (21.8%) developed POPF. Both DISPAIR (area under the ROC curve (AUC) 0.62) and D-FRS (AUC 0.62) performed suboptimally, both in the pooled validation cohort combining every centre’s data and centre-wise. An updated model, named DISPAIR-FRS, was constructed by combining the most stable predictors from the existing models and incorporating other readily available patient demographics, such as age, sex, transection site, pancreatic thickness at the transection site, and main pancreatic duct diameter at the transection site. Internal-external validation demonstrated an AUC of 0.72, a calibration slope of 0.93, and an intercept of −0.02 for the updated model. Conclusion: The combined updated model of DISPAIR and D-FRS named DISPAIR-FRS demonstrated better performance and can be accessed at www.tinyurl.com/the-dispair-frs.